Open AccessClinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials
Author(s) -
Salvatore Cassese,
Robert A. Byrne,
Tomohisa Tada,
Lamin King,
Adnan Kastrati
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs318
Subject(s) - medicine , percutaneous coronary intervention , drug eluting stent , stent , randomized controlled trial , percutaneous , cardiology , meta analysis , platelet aggregation inhibitor , clinical trial , myocardial infarction , aspirin
The aim of this study was to evaluate benefits and risks of extending dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in the drug-eluting stent era.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom